Post-Menopausal Muscle Performance refers to the functional capacity of skeletal muscle in women following the cessation of ovarian function and the subsequent decline in circulating estrogen and progesterone levels. This phase is characterized by shifts in body composition, including sarcopenia and increased risk of functional decline, directly related to hormonal withdrawal. Clinical focus is placed on preserving muscle mass and strength despite these physiological changes.
Origin
This term is situated at the intersection of geriatric physiology and reproductive endocrinology, specifically addressing the impact of estrogen deficiency on anabolic signaling pathways in muscle tissue. It highlights a specific vulnerability window in female health.
Mechanism
The decline in estrogen reduces anabolic drive, potentially by altering the sensitivity of muscle fibers to growth factors like IGF-1 and by decreasing satellite cell activity necessary for repair and hypertrophy. Furthermore, shifts in substrate utilization favoring lipid oxidation over glucose metabolism can contribute to reduced high-intensity contractile capacity. Mitigation strategies often involve resistance training coupled with attention to protein synthesis signaling to counteract these endocrinologically driven deficits.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.